Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions ...

Weight-loss and diabetes drugs reduced the risk of developing Alzheimer’s, an independent study published Monday showed.The ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

A new study uncovers how widely used weight loss drugs like Ozempic impact various health conditions while posing notable ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took researchers by surprise.

Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues, including ...